Patrick P. Ng

1.8k citations

28 papers · 1.4k indexed · 1 hit paper · h-index 13

Insect Science top 2%
Immunology top 10%
- Immunotherapy and Immune Responses 3
Infectious Diseases top 5%
Genetics top 5%
- Chronic Lymphocytic Leukemia Research 5
- Virus-based gene therapy research 2
Aging top 10%
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 7
Oncology
- CAR-T cell therapy research 5
Hematology
- Multiple Myeloma Research and Treatments 4
Molecular Biology
- Glycosylation and Glycoproteins Research 3
Cell Biology
- Biotin and Related Studies 2

Co-authors: Angela E. Douglas Ronald Levy Debra K. Czerwinski Holbrook E. Kohrt Idit Sagiv-Barfi Betty Chang Manuel L. Penichet Uri Keich
Cited by: Insect Science Immunology Infectious Diseases
Journals: Blood (6 papers)Proceedings of the National Academy of Sciences (3 papers)Cancer Research (3 papers)
Partner nations: United States United Kingdom Spain

In The Last Decade

Patrick P. Ng

26 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Patrick P. Ng

Since Specialization

Citations

This map shows the geographic impact of Patrick P. Ng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick P. Ng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick P. Ng more than expected).

Fields of papers citing papers by Patrick P. Ng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick P. Ng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick P. Ng. The network helps show where Patrick P. Ng may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Patrick P. Ng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick P. Ng Line = papers co-authored together Patrick P. Ng links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	mRNA ADENOSINE METHYLASE promotes drought tolerance through N⁶‐methyladenosine‐dependent and independent impacts on mRNA regulation in Arabidopsis New Phytologist ·Diep R Ganguly,Yong-Fang Li,Arthur J. Bilek,Shalini Tiwari,Patrick P. Ng,Brian D. Gregory,Ramanjulu Sunkar	2024	6
2	P-292 Ongoing phase 1 study of HPN217, a half-life extended tri-specific T cell activating construct (TriTAC) targeting B cell maturation antigen (BCMA) for relapsed/refractory multiple myeloma (MM) Clinical Lymphoma Myeloma & Leukemia ·Sumit Madan,Cally Law,Brea Lipe,Eva Medvedova,Andrew J. Cowan,K. Moschner,Leif Bergsagel,Xavier Leleu,Cyrille Touzeau,Daniel Morillo,Albert Oriol,Raya Mawad,N R Gillham,Salomon Manier,Yifah Yaron,Patrick P. Ng,Al‐Ola Abdallah	2023	1
3	Abstract 2896: DLL3-targeted T cell engager therapy (HPN328) for neuroendocrine prostate cancer Cancer Research ·Sheng‐Yu Ku,Yasutaka Yamada,Patrick P. Ng,J. Carvil,Himisha Beltran	2022	1
4	Abstract 1313: CPI-818: A selective inhibitor of interleukin-2-inducible T-cell kinase (ITK) that inhibits T-cell receptor signaling, promotes Th1 skewing, and achieves objective tumor responses when administered to dogs with T cell lymphomas Cancer Research ·James W. Janc,Craig Hill,Patrick P. Ng,Ehsan Pashay Ahi,Antonett Madriaga,Trang Dao-Pick,R.B. Lincoln,Njeri Njuguna,И. В. Дыбина,Erin K. Bradley,Erik Verner,Douglas H. Thamm,Richard A. Miller,Joseph J. Buggy	2019	3
5	Systems level analysis of the Chlamydomonas reinhardtii metabolic network reveals variability in evolutionary co-conservation Molecular BioSystems ·Amphun Chaiboonchoe,Lila Ghamsari,E S Srima,Patrick P. Ng,Basel Khraiwesh,Ashish Jaiswal,Kenan Jijakli,R. Multikainen,David R. Nelson,Hong Cai,Xinping Yang,Roger L. Chang,Jason A. Papin,Haiyuan Yu,Balaji Santhanam,Kourosh Salehi‐Ashtiani	2016	11
6	Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITKbreakdown → Proceedings of the National Academy of Sciences ·Idit Sagiv-Barfi,Holbrook E. Kohrt,Debra K. Czerwinski,Patrick P. Ng,Betty Chang,Ronald Levy	2015	352
7	Ibrutinib Enhances the Activity of Anti-CD20 Antibodies in an MCL Mouse Model: Effect of Drug at Clinically Relevant Concentrations on ADCC and ADCP Blood ·Patrick P. Ng,Daniel Lu,Juthamas Sukbuntherng,Jutta K. Neuenburg,Danelle F. James,Betty Chang	2015	3
8	Abstract 251: Combining Ibrutinib with immune checkpoint blockade to induce therapeutic antitumor immune response in solid tumors Cancer Research ·Idit Sagiv-Barfi,Holbrook E. Kohrt,Debra K. Czerwinski,Patrick P. Ng,Betty Chang,Ronald Levy	2015	0
9	Low‐diversity bacterial community in the gut of the fruitfly Drosophila melanogaster Environmental Microbiology ·Nancy N. Zearfoss,Patrick P. Ng,Angela E. Douglas	2011	349
10	Escherichia coli-based production of a tumor idiotype antibody fragment – tetanus toxin fragment C fusion protein vaccine for B cell lymphoma Protein Expression and Purification ·Kedar G. Patel,Patrick P. Ng,Shoshana Levy,Ronald Levy,James R. Swartz	2010	14
11	Cell-free production of Gaussia princeps luciferase – antibody fragment bioconjugates for ex vivo detection of tumor cells Biochemical and Biophysical Research Communications ·Kedar G. Patel,Patrick P. Ng,Chiung-Chi Kuo,Shoshana Levy,Ronald Levy,James R. Swartz	2009	19
12	Factoring local sequence composition in motif significance analysis Patrick P. Ng,Uri Keich	2008	2
13	Factoring local sequence composition in motif significance analysis. PubMed ·Patrick P. Ng,Uri Keich	2008	3
14	Conjugation of an anti–transferrin receptor IgG3-avidin fusion protein with biotinylated saporin results in significant enhancement of its cytotoxicity against malignant hematopoietic cells Molecular Cancer Therapeutics ·Tracy R. Daniels‐Wells,Patrick P. Ng,Tracie Delgado,Maureen Lynch,Gary J. Schiller,Gustavo Helguera,Manuel L. Penichet	2007	32
15	A conservative parametric approach to motif significance analysis Uri Keich,Patrick P. Ng	2007	2
16	Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor Blood ·Patrick P. Ng,Gustavo Helguera,Tracy R. Daniels‐Wells,Qiuhua Zhu,José A. Rodríguez,Gary J. Schiller,Benjamin Bonavida,Sherie L. Morrison,Manuel L. Penichet	2006	45
17	Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors Vaccine ·Gustavo Helguera,J M Barros,Yoshiki KARIYA,Patrick P. Ng,Ryan Trinh,Sherie L. Morrison,Manuel L. Penichet	2005	21
18	A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery Biomolecular Engineering ·Tsuneaki Asai,Ryan Trinh,Patrick P. Ng,Manuel L. Penichet,Letitia A. Wims,Sherie L. Morrison	2004	19
19	Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection The Lancet ·Yijun Ruan,Chia Lin Wei,Ai Ee Ling,Vinsensius B. Vega,Johannes Lüthy,Su Yun Se Thoe,Jer-Ming Chia,Patrick P. Ng,Kuo Ping Chiu,Khasyiah,Tao Zhang,Kwai Peng Chan,Huang Zeng-nong,Mah Lee Ng,S. T. Marques,Lisa F. P. Ng,Ee Chee Ren,Lawrence W. Stanton,Philip M. Long,Edison T. Liu	2003	344
20	An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells Proceedings of the National Academy of Sciences ·Patrick P. Ng,J M Barros,Charles E Christian,M. K. Azizov,Seung-Uon Shin,Daniel S. Shin,Sherie L. Morrison,Manuel L. Penichet	2002	63

About Patrick P. Ng

Patrick P. Ng is a scholar working on Genetics, Immunology, Hematology, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), CAR-T cell therapy research (5 papers), Multiple Myeloma Research and Treatments (4 papers), Glycosylation and Glycoproteins Research (3 papers), Immunotherapy and Immune Responses (3 papers), Virus-based gene therapy research (2 papers) and Biotin and Related Studies (2 papers). The work is most often cited by research in Insect Science (284 citations), Immunology (385 citations), Infectious Diseases (299 citations), Genetics (161 citations) and Aging (25 citations). Patrick P. Ng has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Angela E. Douglas, Ronald Levy, Debra K. Czerwinski, Holbrook E. Kohrt, Idit Sagiv-Barfi, Betty Chang, Manuel L. Penichet, Uri Keich, Sherie L. Morrison and Ai Ee Ling. Their work appears in journals such as Blood, Proceedings of the National Academy of Sciences, Cancer Research, Bioinformatics and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact